INCATE
LightNews LightNews
banner
incate.bsky.social
INCATE
@incate.bsky.social
110 followers 98 following 220 posts
INCATE is an incubator dedicated to combating antimicrobial resistance (AMR). We assist early-stage innovators with advice on R&D and funding, access to a collaborative community, and financial support.
Posts Replies Media Videos
incate.bsky.social
Science saves lives — and today we celebrate it.

On #WorldScienceDay, we’re proud to stand with the innovators fighting #AMR. At INCATE, we help turn bold ideas into real impact.

When science meets entrepreneurship, change happens.

#Innovation #GlobalHealth
November 10, 2025 at 6:00 AM
incate.bsky.social
Biotech founders: small startups are outpacing Big Pharma — 57% of 2023 US drug approvals! Agility, innovation & smart systems make the difference. Are your tools helping you scale fast and stay compliant?

Read more ➡️ buff.ly/dydT1O3

#Biotech #Startups #Innovation
How Biotech Startups Beat Big Pharma at Drug Development
Biotech startups now lead drug approvals in the US. Discover how leaner teams outpace Big Pharma—and why document control is key to their success.
buff.ly
November 8, 2025 at 6:00 AM
incate.bsky.social
FDA has approved Meitheal’s IV fosfomycin (Contepo) for adults with complicated UTIs caused by E. coli and Klebsiella pneumoniae.
It’s the only IV epoxide antibiotic approved in the US.

Read here ➡️ www.businesswire.com/news/home/20...

#Antibiotics #DrugDevelopment
www.businesswire.com
November 6, 2025 at 7:44 AM
incate.bsky.social
Our colleague Peter Seiler is already at #BactiVac in Birmingham!
He’s eager to meet researchers and innovators addressing #AMR through vaccine innovation.
Say hi and learn how INCATE supports impactful vaccine projects!

#VaccineDevelopment
November 5, 2025 at 8:38 AM
incate.bsky.social
Scientists at St. Jude have turned bacterial resistance into a weapon against itself — using a modified florfenicol that activates within drug-resistant M. abscessus. A new frontier in #AMR innovation.

Nature Microbiology ➡️ www.nature.com/articles/s41...
Prodrug florfenicol amine is activated by intrinsic resistance to target Mycobacterium abscessus - Nature Microbiology
Florfenicol amine hijacks intrinsic resistance in Mycobacterium abscessus, highlighting that antimicrobial resistance mechanisms can be harnessed for antibiotic activation.
www.nature.com
November 4, 2025 at 7:51 AM
incate.bsky.social
It’s #OneHealthDay! At INCATE, we believe tackling #AMR means protecting the health of people, animals & ecosystems together. By supporting innovators, we turn One Health principles into action for a more sustainable, resilient future.
#Innovation #GlobalHealth
November 3, 2025 at 12:00 PM
incate.bsky.social
New research from VUB & VIB shows engineered phages can deliver bacterial toxins to kill drug-resistant E. coli — a precise, promising alternative to antibiotics. A big step forward in tackling AMR!

Read more ➡️ doi.org/10.1128/spec...

#AMR #PhageTherapy #Innovation
Isolation and characterization of bacteriophages from clinical enterohemorrhagic Escherichia coli strains | Microbiology Spectrum
Characterizing bacteriophages from clinical EHEC isolates is crucial in understanding the mechanisms underlying bacterial evolution and virulence. Despite the clinical relevance of EHEC bacteriophages...
doi.org
November 3, 2025 at 7:28 AM
incate.bsky.social
Haven’t seen them yet? WHO released two key AMR reports on antibacterial pipelines & diagnostics — both show urgent innovation gaps.

At INCATE, we’re backing the innovators changing that.

🔗 buff.ly/2VCrGsG

🔗 buff.ly/5Df88Jk

#AMR #Innovation #GlobalHealth
November 1, 2025 at 6:00 AM
incate.bsky.social
Less than a week left! Apply for PACE 2025 Antibacterial Therapeutics funding — up to £1M per project (total £6M).

Open worldwide | Focus: drug-resistant Gram-negative infections.

🗓️ Deadline: 5 Nov, 23:59 UK
➡️ buff.ly/cBfzdLN

#AMR #Innovation #Funding
October 31, 2025 at 6:00 AM
incate.bsky.social
Heading to @bactivac.bsky.social Birmingham next week? INCATE will be there!

Meet our colleague Peter Seiler and learn how INCATE supports vaccine projects tackling AMR. Let’s connect and drive impact together!

#BactiVacEvents #AMR #VaccineDevelopment
October 30, 2025 at 7:28 AM
incate.bsky.social
💥 Our October Newsletter is out! 💥
- INCATE's first report (2021-2024)
- AMR Conference: poster abstract open
- Milestones from the community
🚀 ...and more!

Read all about it in INCATE's Newsletter ➡ lnkd.in/eSp2K9Jv

Haven't you subscribed yet?
Don't fall behind, subscribe here ➡ lnkd.in/dxq4JtMt
October 29, 2025 at 11:21 AM
Reposted by INCATE
gardp.bsky.social
🔴 Live TODAY!

Join our #REVIVE webinar with Adrian Egli (University of Zürich) & Javier Fernández Domínguez (Pragmatech AI Solutions) on how AI can help detect and predict antimicrobial resistance.

🗓️17:00–18:30 CET

👉 Join here: go.bsky.app/redirect?u=h...

#AMR #Antibiotics #AI #REVIVE
October 28, 2025 at 6:00 AM
incate.bsky.social
Big milestone for INCATE!

Our first report 2021–2024 is out: a journey of bridging academia & industry, supporting ventures, and turning science into impact.

More than a report: a celebration of collaboration, perseverance, and shared purpose.

Read it here ➡️ www.incate.net/celebrating-...
October 28, 2025 at 7:50 AM
incate.bsky.social
Kicking off the week with big news!

Basilea Pharmaceutica is once again sponsoring the Poster Competition at the 10th AMR Conference 2026.

🗓️ Abstracts submission deadline: Jan 7 2026

Info & submission ➡️ amr-conference.com/call-for-abs...
October 27, 2025 at 8:13 AM
incate.bsky.social
Can azithromycin save lives in Africa — without accelerating AMR?
This article explores the dilemma: prevention vs. resistance.
At INCATE, we believe innovation & stewardship must go hand in hand to protect both lives & the antibiotics we rely on.

Read more buff.ly/f6wRu8n

#AMR #GlobalHealth
‘I fear we are sitting on a time bomb.’ Scientists debate mass distribution of antibiotics in Africa
Prophylactic use of azithromycin saves vulnerable children’s lives, but could trigger antibiotic resistance
buff.ly
October 25, 2025 at 5:00 AM
incate.bsky.social
Heading to Lyon for #I4ID2025?

Our colleague Derry Mercer will join the Scientific Advisory Board — come say hi!

I4ID brings together leaders from industry, academia & clinical research to advance innovation against infectious diseases & AMR.

📅 Nov 13–14, 2025
📍 ENS Lyon
➡️ i4id.org/program/
October 24, 2025 at 7:31 AM
incate.bsky.social
Great news from smartbax — they’ve raised €4.7M Pre-Series A to advance their novel antibiotic through preclinical development!

We’re proud at INCATE to have supported them early on and thrilled to see their progress in the fight against #AMR.

Read more 👉 www.globenewswire.com/news-release...
smartbax announces a €4.7 M Pre-Series A round to advance novel antibiotic compound through preclinical stage
Lead antibacterial compound against a novel target in Gram-negative bacteria validated in infection modelsProgressing a platform of small-molecule...
www.globenewswire.com
October 23, 2025 at 8:07 AM
incate.bsky.social
AMR kills 1.27M people each year — we urgently need new solutions. On #WorldPhageDay, we celebrate phages: nature’s powerful allies against bacteria. At INCATE, we support innovators bringing phage therapies to life. Working on one? We want to hear from you! #AMR #Phage
October 22, 2025 at 7:29 AM
incate.bsky.social
The new WHO #AMR report shows 1 in 6 bacterial infections are now resistant to antibiotics — and rising fast.

At INCATE, we know AMR innovation isn’t optional, it’s urgent.
The world needs new antimicrobials — and we’re helping make that happen.

Read here ➡️ www.who.int/publications...
Global antibiotic resistance surveillance report 2025: summary
A summary of a new WHO report presenting a global analysis of antibiotic resistance prevalence and trends, drawing on more than 23 million bacteriologically confirmed cases of bloodstream infections, ...
www.who.int
October 21, 2025 at 9:15 AM
incate.bsky.social
🚀 Getting ready to fundraise? Don’t miss Get Fundraising-Ready: Lawyers’ Insights on Due Diligence with Dr. Umberto Milano

🗓️ Oct 30
🕓 4–5pm CET
📍 Online

Hosted by Peak Spirit Academy & Viopas Venture Consulting.

Registration ➡️ events.teams.microsoft.com/event/f9e160...
October 20, 2025 at 5:31 AM
incate.bsky.social
Have you signed up to our newsletter yet?

Get expert insights, breaking news, and key updates delivered straight to your inbox.

Sign up for our newsletter now ➡️ buff.ly/qCI5lpY

Don't fall behind!
October 15, 2025 at 5:01 AM
incate.bsky.social
PCV13 + PPSV23 in adults 60+: Together is safe, but sequential gives stronger long-term immunity. Supports current STIKO guidance.

Read more ➡️
A randomized trial of simultaneous versus sequential pneumococcal vaccination in elderly
To evaluate whether simultaneous vaccination of the 13-valent pneumococcal conjugate vaccine (PCV13) and the 23-valent polysaccharide vaccine (PPSV23) elicits higher antigen-specific memory B cell…
buff.ly
October 14, 2025 at 5:00 AM
incate.bsky.social
The AMR Conference 2026 Poster Call is open!

AMR Scientists: submit your abstract, share your innovation, and compete for poster prizes of up to €1,000. Don’t miss your chance to be part of the leading AMR event in Basel, March 2026.

📅 Deadline: Jan 7, 2026
Details: ➡️ buff.ly/Mjo5VLj
October 13, 2025 at 11:02 AM
incate.bsky.social
Did you know bacteria have social lives? Who cooperates, cheats, or backstabs — even a microbial Sopranos? Dr. Sally Le Page explores these microbial dramas and their impact on health & the environment.

Listen here ➡️
BBC Audio | The Documentary Podcast | The social lives of bacteria
The microscopic dramas of bacterial loners, crowd-lovers, backstabbers and do-gooders
buff.ly
October 10, 2025 at 5:01 AM
incate.bsky.social
DZIF Start-up Fund: Support for spin-offs in infection research with mentoring + up to €500K funding. Focus: preventive & therapeutic anti-infectives. Apply by Nov 30, 2025!

More info ➡️
The German Center for Infection Research establishes a new funding initiative | German Center for Infection Research
The German Center for Infection Research (DZIF) is launching the DZIF Start-up Fund, a new funding initiative to support spin-offs in translational infection research.
buff.ly
October 9, 2025 at 5:01 AM